sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

University of Rochester Intellectual and Developmental Disabilities Research Center

$213,402

John J Foxe · University Of Rochester · P50 · FY2022 · HD

A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes

$213,125

George L King · Joslin Diabetes Center · R21 · FY2023 · MD

Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)

$213,000

Xuyi Yue · Nemours Children'S Hospital, Delaware · R21 · FY2021 · EB

T cell modulation of COVID-19 disease

$212,500

Nicholas James Maness · Tulane University Of Louisiana · R21 · FY2022 · AI

Clinical Studies Core

$212,201

Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2024 · AI

Critical neutralizing domain-based vaccines against new SARS-like virus hCoV-EMC

$212,167

Lanying Du · New York Blood Center · R21 · FY2014 · AI

Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apex

$211,875

Timothy J Cardozo · New York University School Of Medicine · R21 · FY2025 · AI

Multi-scale analysis of single cell sequencing data to dissect the complexity of influenza infections

$211,875

Christian Forst · Icahn School Of Medicine At Mount Sinai · R21 · FY2021 · AI

Single gene inborn errors of immunity underlying SARS-CoV-2-related multisystem inflammatory syndrome in children: a new approach to tackle a seemingly old puzzle

$211,875

Shen-Ying Zhang · Rockefeller University · R21 · FY2023 · AI

Functional characterization of SARS-CoV-2 myeloid cell receptors as an immunopathogenic mechanisms of COVID-19

$211,875

Jun Wang · New York University School Of Medicine · R21 · FY2022 · AI

Assessment of Zoonotic Risk of Emerging Infections in Companion Animals

$211,802

Laura Brunengraber Goodman · Cornell University · U18 · FY2024 · FD

RAPID: Nanomembranes for the Rapid Detection of SARS-CoV-2 in Biofluids

$211,656

James L McGrath · University Of Rochester · · FY2020 · ENG

Community Driven Approach to Mitigate COVID 19 Disparities in Hawaii's Vulnerable Populations

$211,615

Jerris Robert Hedges · University Of Hawaii At Manoa · U54 · FY2020 · MD

COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS

$211,560

Jie Sun · Mayo Clinic Rochester · R01 · FY2020 · AI

COVID_Breastfeeding with COVID 19 disease: SARS-CoV-2 antibodies in breast milk and disease progression in the first six months of life

$211,460

Sahira Askari Long · Children'S Research Institute · R21 · FY2022 · AI

Multi-dimensional comparison of differentially pathogenic coronaviruses (CoV) in human lung tissue

$211,250

Jean Kyou Lim · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · AI

Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis

$211,250

Amy R. Kontorovich · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · AI

Structural and Metabolic Neuroimaging of ME/CFS Occurring with and without COVID-19 Infection

$211,250

Xiang Xu · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · NS

Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries

$210,516

Nir Hacohen · Broad Institute, Inc. · R61 · FY2024 · CA

Administrative Supplement to Investigate the Effects of Long COVID on SELA study participants

$210,509

Paula Sofia Ramos · Medical University Of South Carolina · R01 · FY2024 · MD

University of Rochester Intellectual and Developmental Disabilities Research Center

A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes

Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)

T cell modulation of COVID-19 disease

Clinical Studies Core

Critical neutralizing domain-based vaccines against new SARS-like virus hCoV-EMC

Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apex

Multi-scale analysis of single cell sequencing data to dissect the complexity of influenza infections

Single gene inborn errors of immunity underlying SARS-CoV-2-related multisystem inflammatory syndrome in children: a new approach to tackle a seemingly old puzzle

Functional characterization of SARS-CoV-2 myeloid cell receptors as an immunopathogenic mechanisms of COVID-19

Assessment of Zoonotic Risk of Emerging Infections in Companion Animals

RAPID: Nanomembranes for the Rapid Detection of SARS-CoV-2 in Biofluids

Community Driven Approach to Mitigate COVID 19 Disparities in Hawaii's Vulnerable Populations

COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS

COVID_Breastfeeding with COVID 19 disease: SARS-CoV-2 antibodies in breast milk and disease progression in the first six months of life

Multi-dimensional comparison of differentially pathogenic coronaviruses (CoV) in human lung tissue

Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis

Structural and Metabolic Neuroimaging of ME/CFS Occurring with and without COVID-19 Infection

Integrated Analysis of SARS-CoV-2 Vaccine Responses During Aging

Evaluation of iDMV-1.0: A Single Dose Self-Amplifying Vaccine for SARS-CoV-2

Virology Resource Core

Immunopathogenesis of SARS-CoV-2 infection

Human epidemiology and response to SARS-CoV-2 (HEROS)

Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries

Administrative Supplement to Investigate the Effects of Long COVID on SELA study participants